Wednesday, September 03, 2008

ARD Awareness : Adhesion Barrier News

Find out about ARD Before you have any surgery!

Adhesion Barrier News

SprayGel is not approved for sale in the United States.
SprayGel is currently under clinical investigations in the U.S.

After much controversy about its capabilities, Tyco, the new owners of Confluent have re-instituted clinical trials for SprayGel in the U.S.A.

If you are interested in becoming part of the study contact Dr. Alan Johns in Fort Worth, TX.

Baylor All Saints Location:
1325 Pennsylvania, Suite 350Fort Worth, Texas 76104
Richland Hills Location:3700 Rufe Snow
Fort Worth, Texas 76180
817-803-6625 Email:

Also Genzyme is requiting for its new product SepraSpray.

Adhesion Prevention

Genzyme has developed a suite of biomaterials used to help improve the outcome of certain types of surgeries. Its Sepra™ line of hyaluronic acid-based products has been clinically shown to reduce the incidence of adhesions following general abdominal and gynecologic surgical procedures. With world-class research and development capabilities, and nearly two decades of experience working with biomaterials, Genzyme is expanding its presence in adhesion prevention through the development of laparascopically applied formulations.Adhesion Prevention publications more >.

In Europe.

No comments: